Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewXY-06-007 is a highly selective and potent "Bump & Hole" TAG Degrader (DC50,6h = 10 nM, T1/2 < 43.2 min). XY-06-007 comprises a cereblon (CRBN) E3 ligase ligand joined by a linker to a (+)-JQ1 (Cat. No. 4499) derivative (the "bump" bearer) that selectively binds the Brd4BD1 L94V variant (the "hole"). In cell lines expressing a fusion of the target protein with the tag, Brd4BD1 L94V, XY-06-007 drives formation of a ternary complex between CRBN and the tagged protein, leading to ubiquitination and subsequent proteasomal degradation of the entire protein. XY-06-007 is highly selective for Brd4BD1 L94V over wild-type, and is broadly selective across the proteome. XY-06-007 can be combined with the dTAG approach to achieve simultaneous degrader-mediated depletion of their respective protein fusions. XY-06-007 is suitable for in vivo studies.
Sold under license from Dana-Farber Cancer Institute
M. Wt | 809.28 |
Formula | C41H41ClN8O8 |
Storage | Store at -20°C |
Purity | ≥98% (HPLC) |
CAS Number | 2757045-94-4 |
PubChem ID | 162526515 |
InChI Key | QTDHGBJLMBQHOW-BPJPHOPQSA-N |
Smiles | COC1=CC=C(C2=C1)N3C([C@H]([C@@H](C)C(NCCCCCNC(COC4=CC=CC(C(N5C6C(NC(CC6)=O)=O)=O)=C4C5=O)=O)=O)N=C2C7=CC=C(Cl)C=C7)=NN=C3C |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 80.93 | 100 |
The following data is based on the product molecular weight 809.28. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 1.24 mL | 6.18 mL | 12.36 mL |
5 mM | 0.25 mL | 1.24 mL | 2.47 mL |
10 mM | 0.12 mL | 0.62 mL | 1.24 mL |
50 mM | 0.02 mL | 0.12 mL | 0.25 mL |
References are publications that support the biological activity of the product.
Nowak et al (2021) Structure-guided design of a "Bump-and-Hole" Bromodomain-based degradation tag. J.Med.Chem. 64 11637 PMID: 34279939
If you know of a relevant reference for XY-06-007, please let us know.
Keywords: XY-06-007, XY-06-007 supplier, XY06007, TAG, Degrades, Degraders, degradation, targets, fusion, proteins, BromoTag, Brd4BD1L94V, Degradation, Platform, 7669, Tocris Bioscience
Citations are publications that use Tocris products.
Currently there are no citations for XY-06-007. Do you know of a great paper that uses XY-06-007 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review XY-06-007 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This brochure highlights the tools and services available from Bio-Techne to support your Targeted Protein Degradation and Induced Proximity research, including:
Degraders (e.g. PROTACs) are bifunctional small molecules, that harness the Ubiquitin Proteasome System (UPS) to selectively degrade target proteins within cells. They consist of three covalently linked components: an E3 ubiquitin ligase ligand, a linker and a ligand for the target protein of interest. Authored in-house, this poster outlines the generation of a toolbox of building blocks for the development of Degraders. The characteristics and selection of each of these components are discussed. Presented at EFMC 2018, Ljubljana, Slovenia